Atomic-level cancer studies – a new challenge to distal interdisciplinary science

Katarzyna Anna Taran

doi:10.48269/MandPH-AFMKU-23-1-002

Published: 2023-04-17

Vol. 1 No. 1 (2023)

Atomic-level cancer studies – a new challenge to distal interdisciplinary science

Katarzyna Anna Taran

Section: review articles

https://doi.org/10.48269/MandPH-AFMKU-23-1-002

Abstract

Background:
Nowadays, the amount of cross disciplinary research in many branches of science is growing dynamically. Multidisciplinary, interdisciplinary and transdisciplinary evaluations are being carried out. Scientific progress, in combination with the development of knowledge and new technical discoveries, allows the most complex problems to be considered in an innovative way, which results in original solutions, not present in the previous, more traditional understanding.

Material and methods:
We reviewed the current data on the evaluation of pathological tissues using current mass spectrometry methods, including advanced isotope ratio mass spectrometry in the first known atomic level cancer studies.

Results:
The first attempts to estimate the stable isotope ratio in pathological tissues appeared as a potentially new method of understanding the biology of cancer. The changes in stable isotope concentration showed the relationship with the fundamentals of cancer – its promotion stage, and the mechanisms of its progression as well as its relationship to the standard prognostic biomarkers. The advanced multidisciplinary analysis of the results of isotope ratio assessment in cancer studies culminated in the creation of ‘The Revolve(r) Heavy Nitrogen Theory of Death’, which explains the phenomena of the proliferation force of cancer cells.

Conclusions:
Stable isotope profiling performed using the highly advanced and creditable isotope ratio mass spectrometry approach reveals the previously unknown area of pathological tissue biology. Overcoming interdisciplinary barriers opens a new branch of medical studies with a potential clinical application. The intriguing results of the first attempts and potential clinical implications should form the basis of the next atomic-level cancer studies projects.

Keywords:

cancer , biomarkers , stable isotopes

Download files

PDF

Citation rules

Taran, Katarzyna Anna. “Atomic-Level Cancer Studies – a New Challenge to Distal Interdisciplinary Science”. Medicine and Public Health, vol. 1, no. 1, Apr. 2023, pp. 1-13, doi:10.48269/MandPH-AFMKU-23-1-002.

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

1. Geho DH, Petricoin EF, Liotta LA. Blasting into the Microworld of Tissue Proteomics: A New Window on Cancer (Commentary re Schwartz S, et al. Protein Profiling in Brain Tumors Using Mass Spectrometry: Feasibility of a New Technique for the Analysis of Protein Expression). Clin Cancer Res. 2004;10:825–827, https://doi.org/10.1158/1078-0432.ccr-1223-3.
Google Scholar

2. Carter JF, Barwick VJ (ed.). Good practice guide for isotope ratio mass spectrometry. FIRMS 2011;2, http://www.forensic-isotopes.org/gpg.html.
Google Scholar

3. Choi BCK, Pak AWP. Multidisciplinarity, interdisciplinarity and transdisciplinarity in health research, services, education and policy: 1. Definitions, objectives, and evidence of effectiveness. Clin Invest Med. 2006;29:351–364, PMID: 17330451.
Google Scholar

4. Choi BCK, Pak AWP. Multidisciplinarity, interdisciplinarity, and transdisciplinarity in health research, services, education and policy: 2. Promotors, barriers, and strategies of enhancement. CIM. 2007;30:224, https://doi.org/10.25011/cim.v30i6.2950.
Google Scholar

5. Choi BCK, Pak AW. Multidisciplinarity, interdisciplinarity, and transdisciplinarity in health research, services, education and policy: 3. Discipline, inter-discipline distance, and selection of discipline. CIM. 2008;31:41, https://doi.org/10.25011/cim.v31i1.3140.
Google Scholar

6. Boon M, Van Baalen S. Epistemology for interdisciplinary research – shifting philosophical paradigms of science. Euro Jnl Phil Sci. 2019;9(16):1–28, https://doi.org/10.1007/s13194-018-0242-4.
Google Scholar

7. Taran K, Frączek T, Kamiński R, Sitkiewicz A, Kobos J, et. al. The first protocol of stable isotope ratio assessment in tumor tissues based on original research. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists. 2015;66(3):288–295, https://doi.org/10.5114/pjp.2015.54963.
Google Scholar

8. Patel PS, Cooper AJM, O’Connell TC, Kuhnle GGC, Kneale CK, et. al. Serum carbon and nitrogen stable isotopes as potential biomarkers of dietary intake and their relation with incident type 2 diabetes: the EPIC-Norfolk study. Am J Clin Nutr. 2014;100:708–718, https://doi.org/10.3945/ajcn.113.068577.
Google Scholar

9. Boriosi JP, Maki DG, Yngsdal-Krenz RA, Wald ER, Porter WP, et. al. Changes in breath carbon isotope composition as a potential biomarker of inflammatory acute phase response in mechanically ventilated pediatric patients. J Anal At Spectrom. 2014;29:599–605, https://doi.org/10.1039/C3JA50331C.
Google Scholar

10. Taran K, Frączek T, Sikora-Szubert A, Sitkiewicz A, Młynarski W, et. al. The first investigation of Wilms’ tumour atomic structure-nitrogen and
Google Scholar

carbon isotopic composition as a novel biomarker for the most individual approach in cancer disease. Oncotarget. 2016;7(47):76726–76734, https://doi.org/10.18632/oncotarget.12521.
Google Scholar

11. Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIVAIDS. 2010;5:463–466, https://doi.org/10.1097/COH.0b013e32833ed177.
Google Scholar

12. Okada M. Commentary: Aspects of epidermal growth factor receptor status: Prognostic factor versus predictive factor. The Journal of Thoracic and Cardiovascular Surgery. 2021;162:678–679, https://doi.org/10.1016/j.jtcvs.2020.07.085.
Google Scholar

13. Kempf E, de Beyer JA, Cook J, Holmes J, Mohammed S, et al. Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review. Br J Cancer. 2018;119:1288–1296, https://doi.org/10.1038/s41416-018-0305-5.
Google Scholar

14. Henry NL, Hayes DF. Cancer biomarkers. Molecular Oncology. 2012;6:140–146, https://doi.org/10.1016/j.molonc.2012.01.010.15. Ortiz MV, Ahmed S, Burns M, Henssen AG, Hollmann TJ, et al. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance
Google Scholar

in Wilms’ tumor. JCI Insight. 2019;4:1–17, https://doi.org/10.1172/jci.insight.127098.
Google Scholar

16. Taran K, Kobos J, Sporny S. Examination of expression of WT1 gene product and CD44 adhesive molecule in nephroblastoma histologic types. Pol J Pathol. 2008;59(3):177–182, PMID: 19097357.
Google Scholar

17. Caldwell RL, Caprioli RM. Tissue Profiling by Mass Spectrometry. A Review of methodology and applications. Molecular & Cellular Proteomics. 2005;4:394–401, https://doi.org/10.1074/mcp.R500006-MCP200.
Google Scholar

18. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 1988;60:2299–2301, https://doi.org/10.1021/ac00171a028.
Google Scholar

19. Aebersold R, Mann M. Mass spectrometry – based proteomics. Nature. 2003;422:198–207, https://doi.org/10.1038/nature01511.
Google Scholar

20. Kebarle P, Verkerk UH. Electrospray: from ions in solution to ions in the gas phase, what we know now. Mass Spectrom Rev. 2009;28(6):898–917, https://doi.org/10.1002/mas.20247.
Google Scholar

21. Römpp A, Guenther S, Schober Y, Schulz O, Takats Z, et. al. Histology by Mass Spectrometry: Label-Free Tissue Characterization Obtained from High-Accuracy Bioanalytical Imaging. Angewandte Chemie International Edition. 2010;49(22):3834–3838, https://doi.org/10.1002/anie.200905559.
Google Scholar

22. Lu M, Faull KF, Whitelegge JP, He J, Shen D, et. al. Proteomics and Mass Spectrometry for Cancer Biomarker Discovery. Biomarker Insights. 2007;2:349–360, PMID: 19662217.
Google Scholar

23. Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics. 2004;3:367–378, https://doi.org/10.1074/mcp.R400007-MCP200.
Google Scholar

24. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 2004;20:777–785, https://doi.org/10.1093/bioinformatics/btg484.
Google Scholar

25. Azad NS, Retool N, Annunziata CM, Miamian L, Whiteley G, et al. Proteomics in clinical trials and practice. Mol Cell Proteomics. 2006;5:1819–1829, https://doi.org/10.1074/mcp.R600008-MCP200.
Google Scholar

26. Alaiya A, Al-Mohanna M, Linder S. Clinical cancer proteomics: promises and pitfalls. J Proteome Res. 2005;4:1213–1222, https://doi.org/10.1021/pr050149f.
Google Scholar

27. Liotta LA, Ferrari M, Petricoin EF. Clinical proteomics: written in blood. Nature. 2003;425:905, https://doi.org/10.1038/425905a.
Google Scholar

28. Alaiya A, Roblick U, Egevad L, Carlsson A, Franzén B, et al. Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol. 2000;21:1–9, https://doi.org/10.1155/2000/351963.
Google Scholar

29. Zhong N, Cui Y, Zhou X, Li T, Han J. Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOFMS/
Google Scholar

30. MS. Tumour Biol. 2015;36:1221–1231, https://doi.org/10.1007/s13277-014-2742-y.
Google Scholar

30. Wiseman JM, Puolitaival S, Takáts Z, Cooks R, Caprioli R. Mass Spectrometric Profiling of Intact Biological Tissue by Using Desorption Electrospray Ionization. Angewandte Chemie. 2005;117(43):7256–7259, https://doi.org/10.1002/ange.200502362.
Google Scholar

31. Wu B, Niehren S, Becker JS. Mass spectrometric imaging of elements in biological tissues by new BrainMet technique-laser microdissection inductively coupled plasma mass spectrometry (LMD-ICP-MS). J Anal At Spectrom. 2011;26:1653–1659, https://doi.org/10.1039/c1ja10106d.
Google Scholar

32. Chen G, Gharib TG, Wang H, Huang CC, Kuick R, et al. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA. 2003;100:13537–13542, https://doi.org/10.1073/pnas.2233850100.
Google Scholar

33. He J, Gornbein J, Shen D, Lu M, Rovai LE. et al. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry. Int J Oncol. 2007;30:145–154, PMID: 17143523.
Google Scholar

34. Alaiya A, Roblick U, Egevad L, Carlsson A, Franzén B, et al. Polypeptide expression in prostate hyperplasia and prostate adenocarcinoma. Anal Cell Pathol. 2000;21:1–9, https://doi.org/10.1155/2000/351963.
Google Scholar

35. De Noo ME, Mertens BJ, Ozalp A, Bladergroen MR, van der Werff MPJ, et al. Detection of colorectal cancer using MALDI-TOF serum protein profiling. Eur J Cancer. 2006;42:1068–1076, https://doi.org/10.1016/j.ejca.2005.12.023.
Google Scholar

36. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572–577, https://doi.org/10.1016/S0140-6736(02)07746-2.
Google Scholar

37. Desouza L, Grigull J, Ghanny S, Dubé V, Romaschin AD, et al. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics. 2007;6(7):1170–1182, https://doi.org/10.1074/mcp.M600378-MCP200.
Google Scholar

38. Zhang DH, Wong LL, Tai LK, Koay ESC, Hewitt RE. Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer. J Cancer Res Clin Oncol. 2005;131:603–608, https://doi.org/10.1007/s00432-005-0674-z.
Google Scholar

39. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, et. al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet. 2003;362:433–439, https://doi.org/10.1016/S0140-6736(03)14068-8.
Google Scholar

40. Chaurand P, DaGue BB, Pearsall RS, Threadgill DW, Caprioli RM. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics. 2001;1:1320–1326, https://doi.org/10.1002/1615-9861(200110)1:10<1320::AID-PROT1320>3.0.CO;2-G.
Google Scholar

41. Fan TWM, Lane AN, Higashi RM, Farag MA, Gao H, et. al. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM). Molecular Cancer. 2009;8:41, https://doi.org/10.1186/1476-4598-8-41.
Google Scholar

42. Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, et al. Perspective: a program to improve protein biomarker discovery for cancer. J Proteome Res. 2005;4:1104–1109, https://doi.org/10.1021/pr050027n.
Google Scholar

43. Gillette MA, Mani DR, Carr SA. Place of pattern in proteomic biomarker discovery. J Proteome Res. 2005;4:1143–1154, https://doi.org/10.1021/pr0500962.
Google Scholar

44. Bischoff R, Luider TM. Methodological advances in the discovery of protein and peptide disease markers. J Chromatogr B. 2004;803:27–40, https://doi.org/10.1016/j.jchromb.2003.09.004.
Google Scholar

45. Geho DH, Munson PJ, Young L, Wulfkuhle J, Petricoin EF. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell. 2003;3:317–325, https://doi.org/10.1016/s1535-6108(03)00086-2.
Google Scholar

46. Télouk P, Puisieux A, Fujii T, Balter V, Bondanese VP, et al. Copper isotope effect in serum of cancer patients. A pilot study. Metallomics. 2015;7:299–308, https://doi.org/10.1039/c4mt00269e.
Google Scholar

47. Larner F, Woodley LN, Shousha S, Moyes A, Humphreys-Williams E, et al. Zinc isotopic coposition of breast cancer tissue. Metallomics. 2015;7:112–117, https://doi.org/10.1039/c4mt00260a.
Google Scholar

48. Taran K, Frączek T, Sitkiewicz A, Paneth P, Kobos J. Rhabdomyosarcoma in children in the light of isotope ratio mass spectrometry. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists. 2015;66(4):383–388, https://doi.org/10.5114/PJP.2015.57251.
Google Scholar

49. Taran K, Frączek T, Sitkiewicz A, Sikora-Szubert A, Kobos J, et al. Hepatoblastoma Biology Using Isotope Ratio Mass Spectrometry: Utility of
Google Scholar

a Unique Technique for the Analysis of Oncological Specimens. Postępy Higieny I Medycyny Doświadczalnej (Online). 2016;70:797–802, https://doi.org/10.5604/17322693.1209211.
Google Scholar

50. Tea I, Martineau E, Antheaume I, Lalande J, Mauve C, et. al. 13 C and 15 N natural isotope abundance reflects breast cancer cell metabolism. Scientific Reports. 2016;6(1):342–351, https://doi.org/10.1038/srep34251.
Google Scholar

51. Balter V, Da Costa AN, Bondanese VP, Nogueira da Costa A, Paky Bondanese V, et. al. Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients. PNAS. 2015;112(4):982–985, https://doi.org/10.1073/pnas.1415151112.
Google Scholar

52. Taran K. Isotope Ratio Mass Spectrometry (IRMS) as a new tool in evaluating pathomechanisms of neoplastic disease with regard to isotope map of children’s organisms in Lodz region (in Polish). Academic habilitation thesis Medical University of Lodz (2015).
Google Scholar

53. Flaherty EA, Ben-David M. Overlap and partitioning of the ecological and isotopic niches. Oikos. 2010;119:1409–1416, https://doi.org/10.1111/j.1600-0706.2010.18259.x.
Google Scholar

54. Fuller BT, Fuller JL, Sage NE, Harris DA, O’Connell TC, et al. Nitrogen balance and δ15N: why you’re not what you eat during pregnancy. Rapid Commun Mass Spectrom. 2004;18:2889–2896, https://doi.org/10.1002/rcm.1708.
Google Scholar

55. Fuller BT, Fuller JL, Sage NE, Harris DA, O’Connell TC, et. al. Nitrogen balance and δ15N: why you’re not what you eat during nutritional stress. Rapid Commun Mass Spectrom. 2005;19:2497–2506, https://doi.org/10.1002/rcm.2090.
Google Scholar

56. Kraft RA, Jahren AH, Saudek CD. Clinical-scale investigation of stable isotopes in human blood: δ13C and δ15N from 406 patients at the Johns Hopkins Medical Institutions. Rapid Commun Mass Spectrom. 2008;22:3683–3692, https://doi.org/10.1002/rcm.3780.
Google Scholar

57. Gordon GW, Monge J, Channon MB, Wu Q, Skulan JL, et. al. Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition. Leukemia. 2014;28(10):2112–2115, https://doi.org/10.1038/
Google Scholar

leu.2014.193.
Google Scholar

58. Taran K. Metabolic reprogramming and altered isotope fractionation of cancerous cells of neural origin in the light of advanced atomic level (Oral presentation including The Revolve(r) Heavy Nitrogen Theory of Death). 31st European Congress of Pathology Pathology is Nice, 7–11 September 2019, Nice, France. Virchows Archiv. 2019;63:403, https://doi.org/10.1007/s00428-019-02631-8.
Google Scholar

Vol. 1 No. 1 (2023)
Published: 2023-04-17

eISSN: 2956-9443

Publisher

AFM Publishing House of the Andrzej Frycz Modrzewski Krakow University

Licence CC

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Submit